ArticleCancer immunology, immunotherapy : CII2021

Mechanism of action of a T cell-dependent bispecific antibody as a breakthrough immunotherapy against refractory colorectal cancer with an oncogenic mutation.

Daisuke Kamakura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.